ArticleBMC cancer2020

LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target.

Catharina Hagerling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.